Skip to main content
. 2012 Nov 10;2(6):e001469. doi: 10.1136/bmjopen-2012-001469

Table 2.

Baseline patient sociodemographic and clinical information of the intervention and control groups (mean and range unless otherwise stated)

Intervention Control
Sociodemographic profile
 Number 95 80
 Age (years) 66 (39–82) 62 (42–87)
 Male (%) 50 (52%) 46 (57%)
 Duration of education (years) (SD) 12.22 (4.83) (8–45*) 11.49 (2.74) (2–22)
 Ethnicity white (%) 85 (89.5%) 71 (88.8%)
Clinical profile
 Duration of diabetes (years) (SD) 8.4 (4.1) (1–25) 7.07 (3.83) (1–16)
 HbA1c (IFCC HbA1c mmol/mol) in past 12 months (%) (SD) 8.6 {70} (1.9) 8.8 {73} (0.98)
(7.4–13.1) {57–120} (7.5–11.5) {58–102}
Number with diabetic complications (%)
 Coronary heart disease 29/93 (31.1) 13/80 (16.2)
 Peripheral vascular disease 3/93 (3.22) 3/80 (3.75)
 Stroke 8/93 (8.6) 5/80 (6.25)
 Retinopathy 20/93 (21.5) 10/80 (12.5)
 Nephropathy 5/93 (5.37) 10/80 (12.5)
 Neuropathy 5/93 (5.37) 3/80 (3.75)
Number with comorbidities (%)
 Hypertension 58/93 (62.3) 43/80 (53.75)
 Dyslipidaemia 52/93 (55.9) 38/80 (47.5)
Health service utilisation
Number of diabetes-related visits to the general practice in the past 6 months (SD)
 General practitioners 0.92 (1.13) (0–5) 1.41 (1.68) (0–11)
 Nurse 2.15 (1.84) 1.89 (1.36)
 Number of diabetes-related visits to the hospital in the past 6 months (SD) 0.51 (0.87) 0.45 (0.67)
 Length of consultation (min) 15.31 (2–39) 16.95 (5–45)

*Self-report (this figure includes self-taught continuing education outwith a formal educational programme).